JAM-A functions as a female microglial tumor suppressor in glioblastoma.
Saved in:
| Title: | JAM-A functions as a female microglial tumor suppressor in glioblastoma. |
|---|---|
| Authors: | Turaga SM; Department of Biological, Geological, and Environmental Sciences, Cleveland State University, Cleveland, Ohio.; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Silver DJ; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Bayik D; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Paouri E; Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Peng S; Cancer and Cell Biology Division, TGen, Phoenix, Arizona., Lauko A; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Alban TJ; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case, Western Reserve University, Cleveland, Ohio., Borjini N; Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Stanko S; Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Naik UP; Cardeza Center for Vascular Biology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania., Keri RA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Pharmacology and Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio., Connor JR; Department of Neurosurgery, Penn State College of Medicine, Hershey, Pennsylvania., Barnholtz-Sloan JS; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio., Rubin JB; Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri., Berens M; Cancer and Cell Biology Division, TGen, Phoenix, Arizona., Davalos D; Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case, Western Reserve University, Cleveland, Ohio., Lathia JD; Department of Biological, Geological, and Environmental Sciences, Cleveland State University, Cleveland, Ohio.; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case, Western Reserve University, Cleveland, Ohio.; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio. |
| Source: | Neuro-oncology [Neuro Oncol] 2020 Nov 26; Vol. 22 (11), pp. 1591-1601. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noaa148 |
